Patents by Inventor Peter Kempter

Peter Kempter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110098466
    Abstract: The invention relates to a process for the preparation of compounds of the general formula (I) where X are halogen atoms, the rings labeled A are linearly or angularly fused in position 1,2; 2,3 or 3,4, and in position 8,9; 9,10 or 10,11, to a 5- or 6-membered heterocyclic ring containing in the ring one nitrogen atom and one oxygen atom, or containing in the ring two nitrogen atoms, comprising an oxidation of a 3,6-bisarylamino-2,5-dihalobenzoquinone of the formula (II) in an aprotic-polar organic solvent in the presence of an organic sulfonic acid.
    Type: Application
    Filed: June 12, 2006
    Publication date: April 28, 2011
    Applicant: CLARIANT FINANCE (BVI) LIMITED
    Inventors: Peter Kempter, Wilhelm Streck
  • Patent number: 7686883
    Abstract: A pigment preparation which is characterized by a content in a) a benzimidazolonedioxazine compound of formula (I) as base pigment and b) a dioxazine compound of the general formula (IV) as pigment dispersant wherein Q represents an m-valent radical of a compound of formula (III), wherein m is a number from 1 to 4.
    Type: Grant
    Filed: April 29, 2006
    Date of Patent: March 30, 2010
    Assignee: Clariant Produkte (Deutschland) GmbH
    Inventors: Peter Kempter, Sven Antes, Herbert Graf, Magali Meder
  • Publication number: 20090121202
    Abstract: A pigment preparation which is characterized by a content in a) a benzimidazolonedioxazine compound of formula (I) as base pigment and b) a dioxazine compound of the general formula (IV) as pigment dispersant wherein Q represents an m-valent radical of a compound of formula (III), wherein m is a number from 1 to 4.
    Type: Application
    Filed: April 29, 2006
    Publication date: May 14, 2009
    Inventors: Peter Kempter, Sven Antes, Herbert Graf, Magali Meder
  • Patent number: 6762299
    Abstract: A mixed crystal of two or more different benzimidazolonedioxazine compounds of the formula (1) where X and X′ are identical or different and are hydrogen or halogen, R1, R1′, R2 and R2′ are identical or different and are hydrogen, C1-C18 alkyl, trifluoromethyl, C1-C18 alkylcarbonyl, C5-C6 cycloalkyl or phenyl which may be unsubstituted or substituted by one or more halogen atoms, nitro groups, trifluoromethyl, C1-C18 alkyl, C1-C18 alkoxy, C1-C18 alkylcarbonyl and/or C1-C18 alkoxycarbonyl groups. The mixed crystals are of low solubility and feature good fastness properties and red to blue colorations. The mixed crystals are suitable for pigmenting paints, plastics, printing inks, aqueous or solvent-based pigment preparations, electrophotographic toners and developers, powder coating materials, inks, preferably inkjet inks, color filters, and for coloring seed and cosmetics.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: July 13, 2004
    Assignee: Clariant GmbH
    Inventors: Martin U. Schmidt, Peter Kempter, Carsten Plueg, Roland Born
  • Patent number: 6620931
    Abstract: Process for phase conversion of a methyl-substituted, benzimidazolone-fused dioxazine pigment of composition C22H12Cl2N6O4 having the formula (1) or of an isomer or tautomer thereof, which comprises treating the pigment of formula (1) with certain organic solvents. In the course of this phase conversion, 4 novel crystal polymorphs are formed which are called phases II, IV, V and VI and are characterized by means of their X-ray powder diagrams. The novel polymorphs are of low solubility and feature good fastness properties and violet colorations. The novel crystal polymorphs are suitable for pigmenting coating materials, plastics, printing inks, aqueous or solvent-based pigment preparations, electrophotographic toners and developers, powder coating materials, inks, preferably inkjet inks, and color filters, and for coloring seed.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: September 16, 2003
    Assignee: Clariant GmbH
    Inventors: Martin U. Schmidt, Peter Kempter, Roland Born
  • Patent number: 6617453
    Abstract: The triphendioxazine compounds of the general formula (I) in which the rings labeled A in positions 1,2-, 2,3- or 3,4- and 8,9-, 9,10- or 10,11- carry a linearly or angularly fused heterocyclic ring containing at least one nitrogen atom which is substituted or unsubstituted, with the proviso that compounds with only unsubstituted nitrogen atoms and symmetrically disubstituted compounds with C1-2alkyl and unsubstituted phenyl substituents are excluded, are outstanding pigments and are notable over the closest comparable pigments in particular for better migration, light and solvent fastnesses, better heat stability and enhanced colouring power and also better dispersibility and capability to be brought into pigment form. The invention also relates to a process for preparing these triphendioxazine compounds which is characterized by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: September 9, 2003
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Bansi Lal Kaul, Patrick Boeglin, Peter Kempter
  • Publication number: 20020123626
    Abstract: Process for phase conversion of a methyl-substituted, benzimidazolone-fused dioxazine pigment of composition C22H12Cl2N6O4 having the formula (1) 1
    Type: Application
    Filed: October 22, 2001
    Publication date: September 5, 2002
    Inventors: Martin U. Schmidt, Peter Kempter, Roland Born
  • Publication number: 20020091258
    Abstract: A mixed crystal of two or more different benzimidazolonedioxazine compounds of the formula (1) 1
    Type: Application
    Filed: October 24, 2001
    Publication date: July 11, 2002
    Applicant: Clariant GmbH
    Inventors: Martin U. Schmidt, Peter Kempter, Carsten Plueg, Roland Born
  • Patent number: 6359131
    Abstract: The process provides a process for preparing dioxazines by ring closure of a compound of the formula (II) in which R1 is hydrogen or C1-C8 alkyl in the presence of a ring closure agent, which comprises using as reaction medium an aryl alkyl ether of the formula (III) or a mixture of aryl alkyl ethers of the formula (III) in which n is an integer from 0 to 2 and R2 is ethyl if n is 0 or is methyl if n is 1 or 2.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: March 19, 2002
    Assignee: Clariant GmbH
    Inventors: Gert Nagl, Wolfgang Bauer, Peter Kempter
  • Patent number: 6355795
    Abstract: The triphendioxazine compounds of the general formula (I) in which the rings labelled A in positions 1,2-, 2,3- or 3,4- and 8,9-, 9,10- or 10,11- carry a linearly or angularly fused heterocyclic ring containing at least one nitrogen atom which is substituted or unsubstituted, with the proviso that compounds with only unsubstituted nitrogen atoms and symmetrically disubstituted compounds with C1-2alkyl and unsubstituted phenyl substituents are excluded, are outstanding pigments and are notable over the closest comparable pigments in particular for better migration, light and solvent fastnesses, better heat stability and enhanced coloring power and also better dispersibility and capability to be brought into pigment form. The invention also relates to a process for preparing these triphendioxazine compounds which is characterized by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: March 12, 2002
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Patrick Boeglin, Bansi Lal Kaul, Peter Kempter
  • Patent number: 6255482
    Abstract: The triphendioxazine compounds of the general formula (I) in which the rings labelled A in positions 1,2-, 2,3- or 3,4- and 8,9-, 9,10- or 10,11- carry a linearly or angularly fused heterocyclic ring containing at least one nitrogen atom which is substituted or unsubstituted, with the proviso that compounds with only unsubstituted nitrogen atoms and symmetrically disubstituted compounds with C1-2alkyl and unsubstituted phenyl substituents are excluded, are outstanding pigments and are notable over the closest comparable pigments in particular for better migration, light and solvent fastnesses, better heat stability and enhanced colouring power and also better dispersibility and capability to be brought into pigment form. The invention also relates to a process for preparing these triphendioxazine compounds which is characterized by a cyclization step conducted in the presence of manganese dioxide and concentrated sulphuric acid.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: July 3, 2001
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Patrick Boeglin, Bansi Lal Kaul, Peter Kempter
  • Patent number: 6162261
    Abstract: The invention relates to triphendioxazine compounds of the formula (I) ##STR1## where the rings marked with A comprise, independently of one another, rings which are fused linearly in positions 2,3 and 9,10 or angularly in positions 1,2 and 8,9 or 3,4 and 10,11 and have the radical members of the formula (i) --NR.sub.1 (CO).sub.m --NH--, (ii) --CR.sub.1 .dbd.CH--CO--NH--, (iii) --O--CH.sub.2 --CO--NH--, (iv) --CO--CH.dbd.CR.sub.1 --NH--, (v) --CO--NH--CO--NH--, (vi) --CO--NH--CR.sub.2 .dbd.N--, (vii) --CR.sub.2 .dbd.N--CO--NH--, (viii) --NR.sub.1 --(CO).sub.m --O--, (ix) --NH--CR.sub.1 .dbd.N--, (x) --NH--CO--CR.sub.1 .dbd.N--, (xi) --NH--CO--CHR.sub.1 --NH--, (xii) --NR.sub.3 --(CO).sub.m --NR.sub.4 --, (xiii) --NR.sub.5 --(CO).sub.m --NR.sub.6 --, (xiv) --NR.sub.4 --CO--O-- or (xv) --NR.sub.6 --CO--O--,m is 1 or 2,R.sub.1 is hydrogen, C.sub.1-4 alkyl or phenyl, preferably hydrogen, methyl or ethyl,R.sub.2 is hydrogen, C.sub.1-4 alkyl or phenyl, preferably hydrogen, methyl or ethyl,R.sub.3, R.sub.4, R.sub.
    Type: Grant
    Filed: June 24, 1998
    Date of Patent: December 19, 2000
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Peter Kempter, Bansi Lal Kaul
  • Patent number: 5565563
    Abstract: Triphendioxazine compounds of formula I, ##STR1## in which R.sub.1 and R.sub.2 are either both hydrogen or form a single chain linking the 8,9-; 9,10- or 10,11-positions, the single chain having the formula --NR.sub.5 ---(CO).sub.m --NH--, --CR.sub.5 .dbd.CH--CO--NH--, --CO--CH.sub.2 --CO--NH--, --CO--CH.dbd.CR.sub.5 --NH--, --CO--NH--CO--NH--, --CO--NH--CR.sub.6 .dbd.N--, --CR.sub.6 .dbd.N--CO--NH--, --NR.sub.5--(CO).sub.m --O--or --NH--CR.sub.5 .dbd.N--whereR.sub.5 is hydrogen, C.sub.1-4 alkyl or phenyl, R.sub.6 is hydrogen, C.sub.1-4 alkyl or phenyl;m is 1 or 2 and R.sub.3 and R.sub.4 are either both hydrogen or form a single chain linking the 1,2-, 2,3- or 3,4-positions, the single chain having a formula selected from --NR.sub.5 --(CO).sub.m --NH--, --CR.sub.5 .dbd.CH--CO--NH--, --O--CH.sub.2 --CO--NH--, --CO--CH.dbd.CR.sub.5 --NH--, --CO--NH--CO--NH--, --CONH--CR.sub.6 .dbd.N--, --CR.sub.6 .dbd.N--CO--NH--, --NR.sub.5 --(CO).sub.m --O--or --NH--CR.sub.5 .dbd.N--where the symbols R.sub.5, R.sub.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: October 15, 1996
    Assignee: Sandoz Ltd.
    Inventors: Bansi L. Kaul, Peter Kempter